Intelligent Investor

AdAlta Limited (ASX: 1AD) - Announcements

Current share price for 1AD : $0.027 0.001 (1.85%)

ASX company news and announcements for AdAlta Limited (1AD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AdAlta Limited (1AD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AdAlta Limited (1AD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AdAlta Limited (1AD)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$14 Prospectus 3 Nov 2023 9:46AM $0.023 $0.027 $0.031 risen by 15.22%
$14 Placement to raise up to $1.23million 3 Nov 2023 9:40AM $0.023 $0.027 $0.031 risen by 15.22%
$14 Trading Halt 3 Nov 2023 9:06AM $0.023 $0.027 $0.031 risen by 15.22%
$14 Investor Presentation 27 Oct 2023 8:27AM $0.023 $0.027 $0.031 risen by 15.22%
$14 Quarterly Appendix 4C and Activities Report 27 Oct 2023 8:16AM $0.023 $0.027 $0.031 risen by 15.22%
$14 AD-214 well tolerated in Phase I extension study 23 Oct 2023 8:20AM $0.024 $0.027 $0.031 risen by 10.42%
$14 Letter to Shareholders, Notice of AGM & Proxy Form 20 Oct 2023 10:00AM $0.025 $0.027 $0.031 risen by 8.16%
$14 AD-214 oral presentation at MPGPCR23 19 Oct 2023 8:18AM $0.024 $0.027 $0.031 risen by 10.42%
$14 R&D tax refund received & R&D Loan repayment terms extended 18 Oct 2023 8:23AM $0.024 $0.027 $0.031 risen by 10.42%
$14 Investor roadshow with IPF survivor Bill van Nierop 13 Oct 2023 11:22AM $0.023 $0.027 $0.031 risen by 15.22%
$14 Notification regarding unquoted securities - 1AD 12 Oct 2023 11:49AM $0.023 $0.027 $0.031 risen by 15.22%
$14 Notification of cessation of securities - 1AD 12 Oct 2023 11:45AM $0.023 $0.027 $0.031 risen by 15.22%
$14 Cleansing Notice under Section 708A 27 Sep 2023 8:24AM $0.022 $0.027 $0.031 risen by 20.45%
$14 Application for quotation of securities - 1AD 27 Sep 2023 8:20AM $0.022 $0.027 $0.031 risen by 20.45%
$14 Prof Foley invited presentation AD-214 26 Sep 2023 8:19AM $0.020 $0.027 $0.031 risen by 32.50%
$14 Dosing simulations support AD-214 IV product profile 25 Sep 2023 8:20AM $0.022 $0.027 $0.031 risen by 20.45%
$14 Notification of Date of 2023 AGM 22 Sep 2023 9:25AM $0.020 $0.027 $0.031 risen by 32.50%
$14 AD-214 Phase I extension study fully enrolled 20 Sep 2023 8:18AM $0.022 $0.027 $0.031 risen by 20.45%
$14 Appendix 4G and Corporate Governance Statement 25 Aug 2023 5:32PM $0.023 $0.027 $0.031 risen by 15.22%
$14 Annual Report to shareholders 25 Aug 2023 5:31PM $0.023 $0.027 $0.031 risen by 15.22%
$14 Preliminary Final Report 25 Aug 2023 5:27PM $0.023 $0.027 $0.031 risen by 15.22%
$14 Investor webinar - recent AD-214 progress 7 Aug 2023 9:05AM $0.024 $0.027 $0.031 risen by 10.42%
$14 AD-214 returns to clinic 4 Aug 2023 8:21AM $0.023 $0.027 $0.031 risen by 15.22%
$14 Change in substantial holding 21 Jul 2023 9:10AM $0.024 $0.027 $0.031 risen by 10.42%
$14 Change in substantial holding 14 Jul 2023 5:15PM $0.025 $0.027 $0.031 risen by 6%

51 - 75 of 526 results

Page 3 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.